Izraēla -
ivrits -
Ministry of Health
לכה לציפורניים laline
תעשיות תמרוקים שיק 1989 בעמ - צביעת ציפורניים
Izraēla -
ivrits -
Ministry of Health
לכה לציפורניים laline
תעשיות תמרוקים שיק 1989 בעמ - צביעת ציפורניים
Izraēla -
ivrits -
Ministry of Health
ארומזין
pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
Izraēla -
ivrits -
Ministry of Health
לוקרין פ.ד.ס דפו 11.25 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin
Izraēla -
ivrits -
Ministry of Health
לוקרין פ.ד.ס דפו 11.25 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin
Izraēla -
ivrits -
Ministry of Health
לוקרין פ.ד.ס דפו 3.75 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 3.75 mg - leuprorelin
Izraēla -
ivrits -
Ministry of Health
לוקרין פ.ד.ס דפו 3.75 מג
abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 3.75 mg - leuprorelin
Izraēla -
ivrits -
Ministry of Health
גברטו
roche pharmaceuticals (israel) ltd - pralsetinib - קפסולה קשיחה - pralsetinib 100 mg - pralsetinib
Izraēla -
ivrits -
Ministry of Health
כולבם 250 מג
megapharm ltd - cholic acid - קפסולה קשיחה - cholic acid 250 mg - cholic acid
Izraēla -
ivrits -
Ministry of Health
כולבם 50 מג
megapharm ltd - cholic acid - קפסולה קשיחה - cholic acid 50 mg - cholic acid